1. Group A Streptococcal Brain Abscess in the Pediatric Population
- Author
-
Galia Grisaru-Soen, Shlomi Constantini, Efraim Bilavsky, Tali Capua, Amir Klivitsky, Jonathan Roth, and Liat Ashkenazi-Hoffnung
- Subjects
Male ,Microbiology (medical) ,Mastoiditis ,Pediatrics ,medicine.medical_specialty ,Fever ,Brain Abscess ,03 medical and health sciences ,Lethargy ,0302 clinical medicine ,Streptococcal Infections ,030225 pediatrics ,medicine ,Humans ,030212 general & internal medicine ,Sinusitis ,Brain abscess ,business.industry ,Incidence (epidemiology) ,Brain ,Infant ,Streptococcus ,medicine.disease ,Anti-Bacterial Agents ,Otitis Media ,Treatment Outcome ,Infectious Diseases ,Otitis ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Vomiting ,Female ,medicine.symptom ,Tomography, X-Ray Computed ,business ,Meningitis - Abstract
Background Group A Streptococcus (GAS) is a rare cause of central nervous system infections. Methods We describe 3 new cases of GAS brain abscess in previously healthy children treated by us between 2015 and 2016 and review the 5 cases reported in the literature since 1988. Results All 8 children received early empiric antibiotic therapy and surgical intervention, and 5 made a full recovery. Conclusions GAS brain abscess is a rare infection; however its incidence may be rising. We suggest that if patients show symptoms such as fever, vomiting and lethargy, with contiguous infection such as otitis media, mastoiditis, sinusitis or meningitis, GAS brain abscess should be suspected. Prognosis is expected to be good with early implementation of appropriate treatment.
- Published
- 2018
- Full Text
- View/download PDF